Repurchase Agreements in the Biotechnology Industry
23 Contracts & Agreements
- AGENUS INC (1 contract)
- AGIOS PHARMACEUTICALS INC (1)
- Alliqua BioMedical, Inc. (1)
- Amgen Inc. (1)
- Anika Therapeutics (3)
- Arbutus Biopharma Corp (2)
- Axcella Health Inc. (1)
- CTI BIOPHARMA CORP (1)
- CYTORI THERAPEUTICS, INC. (1)
- Emerald Bioscience, Inc. (1)
- Inmune Bio, Inc. (1)
- Minerva Neurosciences, Inc. (1)
- Organogenesis Holdings Inc. (1)
- Regeneron Pharmaceuticals (1)
- Savara Inc (1)
- Synthetic Biologics, Inc. (1)
- United Therapeutics Corp (1)
- Viking Therapeutics, Inc. (2)
- Virios Therapeutics, LLC (1)
Recent Contracts
Category
Company
Industry
Jur.
Filed
Repurchase Agreements
Biotechnology
NV
2014
Repurchase Agreements
Biotechnology
DE
2024
Repurchase Agreements
Biotechnology
DE
2024
Master Confirmation Accelerated Share Repurchase, between the Company and Citi, dated March 25, 2024
Repurchase Agreements
Biotechnology
NY
2024
Repurchase Agreements
Biotechnology
DE
2022
Repurchase Agreements
Biotechnology
NY
2021
Repurchase Agreements
Biotechnology
NY
2020
Repurchase Agreements
Biotechnology
NY
2019
Repurchase Agreements
Biotechnology
DE
2019
Repurchase Agreements
Biotechnology
NY
2018
Repurchase Agreements
Biotechnology
NY
2016
Repurchase Agreements
Biotechnology
CA
2015
Repurchase Agreements
Biotechnology
NY
2011
Repurchase Agreements
Biotechnology
NY
2008
Repurchase Agreements
Biotechnology
2005